Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v1-EN
Language English English
Date Updated 2023-01-12 2022-10-28
Drug Identification Number 02230418 02230418
Brand name IMITREX IMITREX
Common or Proper name Sumatriptan nasal spray Sumatriptan nasal spray
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients SUMATRIPTAN SUMATRIPTAN
Strength(s) 5MG 5MG
Dosage form(s) SPRAY SPRAY
Route of administration NASAL NASAL NASAL NASAL
Packaging size 2s 2s
ATC code N02CC N02CC
ATC description ANTIMIGRAINE PREPARATIONS ANTIMIGRAINE PREPARATIONS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2022-10-28 2022-10-28
Estimated end date 2023-01-13 2022-11-28
Actual end date 2023-01-11
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments